Op2Lysis
PrivateLast Round
Series A
Nov 4, 2024
Total Funding Raised
$12.55M
Company Overview
Op2Lysis is a biotechnology company that develops innovative medicines for the treatment of hemorrhagic stroke using its proprietary NANOp2Lysis® technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Op2Lysis Comparables
Compare Op2Lysis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bioxodes | 86% | |
| Lys Therapeutics | 77% | |
| Basking Biosciences | 75% |
Op2Lysis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 4, 2024 | ||||
| Grant | Jul 7, 2023 | ||||
| Accelerator | Oct 1, 2021 | ||||
| Early Funding | Dec 1, 2020 | ||||
| Seed | Apr 1, 2018 |
Key People
Founding team and executive leadership
Op2Lysis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Accelerator |
| Noshaq | Early Funding |
| WiSeed | Seed |
| Bpifrance | Grant |
| BeAngels | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 4, 2024
$29.16M Series A round completed.
- Jul 7, 2023
$1.65M grant received from Bpifrance.
Op2Lysis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Op2Lysis's valuation, stock price, and market status.
Is Op2Lysis a public or private company?
Op2Lysis is a private company.
What is the current stock price of Op2Lysis?
Op2Lysis is a private company with no public stock price. Caplight tracks Op2Lysis's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Op2Lysis worth (valuation)?
Valuation information for Op2Lysis is not publicly available.
Can I buy Op2Lysis stock?
Op2Lysis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Op2Lysis's last funding round?
Op2Lysis's most recent funding round was Series A on November 4, 2024.
Who are the main investors in Op2Lysis?
Key investors in Op2Lysis include European Innovation Council Fund, Noshaq, WiSeed, Bpifrance, BeAngels.
Will Op2Lysis IPO soon?
No public IPO plans have been announced for Op2Lysis.
How can I track Op2Lysis secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Op2Lysis's secondary market activity and sign up for updates.